IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Amkay Products Ltd.
Issue Open Date 30-Apr-24  
Issue Closing Date 03-May-24  
Application Money 100  
Allotment Money  
Price Band 52 - 55  
Minimium Application No. 2000  
Issue Size (Shares) 1642000  
Market Lot 1.00  
Objective
1. Funding Capital Expenditure towards installation of additional Machinery;2. To meet working capital requirements; and3. General Corporate Purpose.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   446000   321994000   721.96  
Qualified Institutional Buyers   434000   75098000   173.04  
Retail Individual Investors   762000   741530000   973.14  
Business Description
We manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Productslike Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers,hospitals/clinics, nu
more...
Promoter's Holding
Total Share Capital   6356510  
Offered to Public   2292000  
Promoter's Holding (Pre-Issue)   99.89  
Promoter's Holding (Post-Issue)   73.44  
Address
Bunglow No. 68
Rashmi Park
C H S Ltd
Dhumal Nagar
Waliv Road
Vasai
Thane ,
Maharashtra ,
401208
Phone: 9152094440
Email: cs@amkayproducts.com
Website: www.amkayproducts.com
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
BSE
Lead Manager
Hem Securities Ltd.
Promoters
Hemanshu Kantilal Batavia
Kashyap Pravin Mody
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.